Sign in

CIK 0001661053

  • Non-accelerated filer
  • Smaller reporting company

enVVeno Medical Corp

Sign in to watch
Ticker
NVNO
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330936180
Phone
+1 949-261-2900
Business address
70 DOPPLER, IRVINE, CA, 92618
Former names
Hancock Jaffe Laboratories, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$123
in 1 filing, $123 under 10b5-1 plans

Net −$123. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Duhay Francis −$123 Director sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2025-12-16 BERMAN ROBERT ANDREW Chief Executive Officer Other disposition · Restricted Stock Units −200,000 0
2024-12-19 BERMAN ROBERT ANDREW Chief Executive Officer Purchase +12,000 $2.55 $31K 222,236
2024-12-18 BERMAN ROBERT ANDREW Chief Executive Officer Grant or award · Stock Options +200,000 200,000
2023-12-05 BERMAN ROBERT ANDREW Chief Executive Officer Grant or award · Stock Options +300,000 300,000
2022-06-27 BERMAN ROBERT ANDREW Chief Executive Officer Purchase +2,500 $3.80 $10K 210,236
2021-11-30 BERMAN ROBERT ANDREW Chief Executive Officer Grant or award +200,000 207,736
2021-11-30 BERMAN ROBERT ANDREW Chief Executive Officer Grant or award · Stock Options +349,781 349,781
2021-11-19 BERMAN ROBERT ANDREW CEO Purchase +2,000 $7.43 $15K 7,736
2021-11-16 BERMAN ROBERT ANDREW CEO Purchase +2,000 $7.87 $16K 5,736
2021-05-18 BERMAN ROBERT ANDREW Chief Executive Officer Purchase +3,000 $5.47 $16K 3,736
2021-02-18 BERMAN ROBERT ANDREW Chief Executive Officer Grant or award · Stock Option +838,000 838,000
2020-07-18 BERMAN ROBERT ANDREW CEO Other disposition · Stock Option −1,080,207 0
2020-07-18 BERMAN ROBERT ANDREW CEO Grant or award · Stock Option +1,080,207 1,080,207
2020-07-18 BERMAN ROBERT ANDREW CEO Grant or award · Stock Option +1,000,000 1,000,000
2019-03-12 BERMAN ROBERT ANDREW Chief Executive Officer Purchase +18,382 $1.36 $25K 18,382
2019-03-12 BERMAN ROBERT ANDREW Chief Executive Officer Purchase +21,740 $1.15 $25K 21,740
2018-09-24 BERMAN ROBERT ANDREW Chief Executive Officer Grant or award · Stock Option (Right to Buy) +1,080,207 $2.71 $2.9M 1,080,207

Page 1 of 1 · 17 trades